3938 Trust Way
Hayward, CA 94545
Phone: 510-785-2564
www.biolog.com

Timothy Mullance, president and CEO
Privately Held

Overview

Formed in 1984, Biolog develops cellular analysis tools for solving problems in pharmaceutical and biotechnology research and development. Its proprietary technologies are designed to allow scientists to broadly characterize cellular functions using phenotype test arrays that measure cell respiration

The MicroLog identification system identifies more than 2,000 microbial species, covering virtually all the important human, animal and plant pathogens, as well as a large number of environmental microorganisms.

The company is expanding its program into genomics and drug development aimed at both microbial cells and mammalian cells using a new Phenotype MicroArray technology platform. The platform includes data from 400 phenotypes from the following microbial species: Burkholderia cepacia, Escherichia coli, Listeria innocua, Listeria monocytogenes, Pseudomonas aeruginosa, Ralstonia pickettii, Ralstonia solanacearum, Salmonella typhimurium, Sinorhizobium meliloti and Vibrio fluvialis.

Partners

Partners include Paradigm Genetics Inc. to use the Phenotype MicroArray technology to determine gene function in agriculturally important fungal species.